Nuveen Asset Management LLC Sells 3,954 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)

Nuveen Asset Management LLC decreased its position in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 4.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 93,170 shares of the company's stock after selling 3,954 shares during the period. Nuveen Asset Management LLC owned about 0.30% of iRhythm Technologies worth $8,401,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in IRTC. R Squared Ltd bought a new stake in iRhythm Technologies during the fourth quarter worth about $45,000. Van ECK Associates Corp lifted its holdings in shares of iRhythm Technologies by 41.3% during the fourth quarter. Van ECK Associates Corp now owns 554 shares of the company's stock valued at $50,000 after purchasing an additional 162 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of iRhythm Technologies by 166.6% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,037 shares of the company's stock worth $94,000 after purchasing an additional 648 shares in the last quarter. KBC Group NV grew its stake in shares of iRhythm Technologies by 45.1% in the 4th quarter. KBC Group NV now owns 1,319 shares of the company's stock worth $119,000 after buying an additional 410 shares during the last quarter. Finally, Xponance Inc. bought a new position in iRhythm Technologies during the 4th quarter valued at approximately $203,000.

iRhythm Technologies Stock Performance

iRhythm Technologies stock traded down $0.87 during mid-day trading on Friday, reaching $141.37. 787,545 shares of the stock traded hands, compared to its average volume of 480,444. The stock has a market capitalization of $4.51 billion, a PE ratio of -38.84 and a beta of 1.34. The company has a debt-to-equity ratio of 9.00, a current ratio of 6.27 and a quick ratio of 6.12. The business's 50-day moving average is $117.81 and its 200-day moving average is $104.79. iRhythm Technologies, Inc. has a 12-month low of $55.92 and a 12-month high of $146.58.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported ($0.95) earnings per share for the quarter, missing the consensus estimate of ($0.89) by ($0.06). The business had revenue of $158.68 million for the quarter, compared to analysts' expectations of $153.39 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. The company's revenue was up 20.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($1.23) EPS. As a group, sell-side analysts predict that iRhythm Technologies, Inc. will post -1.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on IRTC shares. Truist Financial increased their target price on iRhythm Technologies from $111.00 to $145.00 and gave the stock a "buy" rating in a research note on Friday, February 21st. Wells Fargo & Company raised shares of iRhythm Technologies from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $104.00 to $130.00 in a report on Friday, May 2nd. Wall Street Zen downgraded shares of iRhythm Technologies from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Robert W. Baird raised their price target on shares of iRhythm Technologies from $133.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, May 2nd. Finally, The Goldman Sachs Group boosted their price objective on shares of iRhythm Technologies from $91.00 to $124.00 and gave the stock a "neutral" rating in a report on Monday, February 24th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat.com, iRhythm Technologies presently has a consensus rating of "Moderate Buy" and an average price target of $133.73.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.